VAT1
VAT1 (Vesicle Amine Transport 1) is a protein that in humans is encoded by the VAT1 gene. This protein is involved in the vesicle transport system and is associated with the storage and release of amine neurotransmitters. VAT1 is considered important in the function of neurotransmitter release mechanisms, particularly in the central nervous system (CNS).
Function[edit | edit source]
VAT1 is believed to play a crucial role in the synaptic vesicle cycle, particularly in the recycling and refilling processes. It is involved in the transport of amines within the vesicles, which are essential for the proper functioning of neuronal communication. The exact mechanism of how VAT1 functions in the vesicle amine transport system is still under investigation, but it is thought to facilitate the storage of amines in synaptic vesicles, making them available for release upon neuronal activation.
Gene[edit | edit source]
The VAT1 gene is located on human chromosome 17q25.3 and consists of multiple exons that encode the VAT1 protein. Variations in this gene may influence the efficiency of neurotransmitter storage and release, potentially impacting neurological disorders and their severity.
Clinical Significance[edit | edit source]
Research suggests that VAT1 may have implications in various neurological and psychiatric conditions, including schizophrenia, bipolar disorder, and depression. Alterations in the expression or function of VAT1 could affect neurotransmitter balance, contributing to the pathophysiology of these disorders. Additionally, VAT1 has been studied in the context of neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, where vesicle transport and neurotransmitter release mechanisms are often disrupted.
Research[edit | edit source]
Ongoing research is focused on elucidating the detailed mechanisms of VAT1 in neurotransmitter release and its potential as a therapeutic target for treating neurological disorders. Studies involving genetic engineering, animal models, and cell culture systems are being conducted to understand the role of VAT1 in the CNS and its implications in disease.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
